Is Zepbound a Semaglutide? What You Need to Know About These Weight Loss Medications

Last reviewed: June 7, 2026

Last updated: June 7, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Many patients ask whether Zepbound contains semaglutide, but the answer is no. Zepbound is the brand name for tirzepatide, a medication that works through a different mechanism than semaglutide, though both belong to the GLP-1 class of drugs. Clinical trials show tirzepatide produces greater weight loss in some patients, making it an important option to consider alongside other available therapies.

Zepbound and Semaglutide Are Not the Same Medication

Zepbound is tirzepatide, a medication approved by the FDA in 2023 for chronic weight management. Semaglutide, sold under brand names like Wegovy, is a separate injectable medication approved earlier for the same purpose. While both are GLP-1 receptor agonists, they activate different pathways in your body. Semaglutide stimulates only the GLP-1 receptor, whereas tirzepatide activates both GLP-1 and GIP receptors, creating a dual-action effect.

The distinction matters because dual-action medications may produce different results in different bodies. In head-to-head clinical trials, tirzepatide showed superior weight loss compared to semaglutide at equivalent timepoints. However, individual response varies based on genetics, metabolism, and lifestyle factors. PlexusDx offers both compounded semaglutide injection and tirzepatide injection so patients can select the medication best suited to their unique physiology.

How Tirzepatide's Dual-Action Mechanism Works

Tirzepatide activates two different hormone receptors in your brain and gut. The GLP-1 receptor helps regulate blood sugar, slows stomach emptying, and increases feelings of fullness. The GIP receptor enhances insulin release and works alongside GLP-1 to further reduce appetite. This combination may explain why tirzepatide users often experience more significant appetite suppression and weight loss than those using single-action medications.

Research published in major medical journals demonstrates that tirzepatide at higher doses produced an average weight loss of 22% of body weight in clinical trials. Semaglutide achieved approximately 17% weight loss at comparable doses. These numbers highlight why some patients and physicians prefer tirzepatide when maximum weight loss efficacy is the goal. Individual outcomes still depend on dose escalation, adherence, and metabolic factors unique to each person.

Semaglutide vs. Tirzepatide: Key Clinical Differences

Semaglutide's single GLP-1 action has been studied extensively over many years, providing long-term safety data and well-established dosing protocols. Tirzepatide is newer, yet clinical evidence shows it reaches target weight loss faster and produces greater magnitude of loss in most patients. Both carry similar side effect profiles—nausea, vomiting, constipation—though severity varies individually. The choice between them depends on your medical history, response goals, and how your genetics influence peptide pathway sensitivity.

The PlexusDx Precision Peptide Genetic Test ($298) analyzes GIPR, FTO, and MC4R — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to tirzepatide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

Why Compounded Tirzepatide Offers Flexibility and Access

Brand-name Zepbound carries high out-of-pocket costs and often requires insurance pre-authorization that can delay treatment. PlexusDx provides compounded tirzepatide injection from licensed 503A pharmacies at $289/mo (or $249/mo on the 6-month plan) across all commitment tiers, with no insurance required and no hidden membership fees. Compounded medications meet the same quality and sterility standards as brand products while offering affordability and immediate access across all 50 states.

Patients choosing tirzepatide through PlexusDx receive injections dosed according to your treatment protocol, with the pricing guarantee that your dose may need to go up—but your price won't. HSA and FSA accounts cover compounded tirzepatide, further reducing your out-of-pocket spending. Many patients find this approach more transparent and cost-effective than navigating insurance formularies for branded alternatives.

Choosing Between Semaglutide and Tirzepatide With PlexusDx

Your choice between semaglutide and tirzepatide should reflect your weight loss goals, medical history, and how your body responds to each medication's mechanism. PlexusDx offers compounded semaglutide injection at $189/mo month-to-month, or from $149/mo on the 6-month plan and compounded tirzepatide injection at $289/mo month-to-month, or from $249/mo on the 6-month plan, giving you flexibility to select based on clinical evidence and personal preference. Both medications are administered weekly via simple subcutaneous injection that you can self-administer at home.

PlexusDx also offers GLP-Squared Injection, a dual compound containing both semaglutide and tirzepatide in a single formulation, at $289/mo month-to-month, or from $249/mo on the 6-month plan for patients seeking a balanced approach. After your first month on any medication, the Precision Peptide Genetic Test ($298) can describe the pathway-level variants involved.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection is $289/mo month-to-month, or from $249/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test ($298) to personalize your protocol from day one.

Frequently Asked Questions

Is Zepbound the same as semaglutide?

No. Zepbound is the brand name for tirzepatide, a dual-action GLP-1 and GIP receptor agonist. Semaglutide is a separate medication that activates only the GLP-1 receptor. Both are injectable weight loss medications, but they work through different mechanisms and produce different results in clinical trials.

Which medication causes more weight loss—semaglutide or tirzepatide?

No — the Precision Peptide Genetic Test does not predict your response to tirzepatide or any specific medication. It analyzes pathway-level variants (GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

How much does compounded tirzepatide cost at PlexusDx?

PlexusDx compounded tirzepatide injection is $289/mo month-to-month (or $249/mo on the 6-month plan) across all commitment tiers, with no insurance required and no membership fees. HSA and FSA funds are eligible. Your dose may increase over time, but your monthly price remains flat—the PlexusDx pricing guarantee.

Are compounded tirzepatide and semaglutide as safe as brand-name versions?

Compounded medications from licensed 503A pharmacies meet identical quality, sterility, and potency standards as brand products. PlexusDx sources all compounds from licensed 503A pharmacies only. Both semaglutide and tirzepatide carry similar side effect profiles (nausea, constipation, vomiting); safety depends on proper dosing and medical oversight, not whether the medication is branded or compounded.

How does PlexusDx Precision Peptide Genetic Test help me choose between semaglutide and tirzepatide?

The test ($298) analyzes your variants in GIPR, FTO, and MC4R, and 10 additional pathways controlling peptide sensitivity and weight regulation. Results reveal genetic predispositions that may favor tirzepatide's dual-action mechanism or semaglutide's single-target approach, helping optimize your medication choice based on your biology.

Related Reading

• Semaglutide For Weight Loss 2
• Semaglutide Tablets For Weight Loss
• Semaglutide Pills For Weight Loss
• Wegovy Vs Zepbound Weight Loss

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.